Can the imaging manifestations of melioidosis prognosticate the clinical outcome? A 6-year retrospective study

Insights into Imaging

Table 2 Association of organ involvement with favourable/unfavourable outcome

Organ involvement	Outcome		Chi-square test	Logistic regression
Organ involvement	Favourable, n (%)	Unfavourable, n (%)	p value	ß-coefficient	Odds ratio (95% CI)	p value
Lungs and pleura
Absent	100 (87)	15 (13)	0.001	1.16	3.20 (1.54–6.63)	0.002
Present	50 (68)	24 (32)	0.001	1.16	3.20 (1.54–6.63)	0.002
CNS
Absent	142 (80)	36 (20)	0.70	0.39	1.48 (0.37–5.85)	0.58
Present	8 (73)	3 (27)	0.70	0.39	1.48 (0.37–5.85)	0.58
Liver
Absent	110 (82)	24 (18)	0.15	0.54	1.72 (0.82–3.60)	0.15
Present	40 (73)	15 (27)	0.15	0.54	1.72 (0.82–3.60)	0.15
Spleen
Absent	76 (76)	24 (24)	0.23	− 0.44	0.64 (0.31–1.32)	0.23
Present	74 (83)	15 (17)	0.23	− 0.44	0.64 (0.31–1.32)	0.23
Pancreas
Absent	146 (80)	37 (20)	0.61	0.68	1.97 (0.35–11.18)	0.44
Present	4 (67)	2 (33)	0.61	0.68	1.97 (0.35–11.18)	0.44
Gut
Absent	129 (80)	33 (20)	0.83	0.11	1.12 (0.42–2.99)	0.83
Present	21(78)	6(22)	0.83	0.11	1.12 (0.42–2.99)	0.83
Musculoskeletal system
Absent	96 (77)	28 (23)	0.36	− 0.35	0.69 (0.32–1.51)	0.36
Present	54 (83)	11 (17)	0.36	− 0.35	0.69 (0.32–1.51)	0.36
Lymph nodes
Absent	120 (76)	37 (24)	0.02	− 1.53	0.22 (0.05–0.95)	0.04
Present	30 (94)	2 (6)	0.02	− 1.53	0.22 (0.05–0.95)	0.04
TB
Absent	130 (78)	37 (22)	0.26	− 1.05	0.35 (0.08–1.57)	0.17
Present	20 (91)	2 (9)	0.26	− 1.05	0.35 (0.08–1.57)	0.17